1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Affiris AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006 AFFITOPE® AD02, Placebo - Alzheimer´s Disease | Phase 2 | Terminated | Affiris AG | 194 | 2013-06-01 | 2015-06-24 |
| Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease active: AFFITOPE AD02, control: Placebo - Alzheimer's Disease | Phase 2 | Completed | Affiris AG | 335 | 2010-09-01 | 2013-12-11 |
Alzheimer Disease (2) · Brain Diseases (1) · Dementia (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Tauopathies (1)
Austria (2) · Croatia (2) · Czechia (2) · France (2) · Germany (2) · Slovakia (2)
Bruno Dubois, Prof (1) · Bruno Dubois, Prof. (1)
2009 (1)